Cargando…
A novel function for platelet-derived growth factor D: induction of osteoclastic differentiation for intraosseous tumor growth
Although increasing evidence suggests a critical role for platelet-derived growth factor (PDGF) receptor β (β-PDGFR) signaling in prostate cancer (PCa) progression, the precise roles of β-PDGFR and PDGF isoform-specific cell signaling have not been delineated. Recently, we identified the PDGF-D isof...
Autores principales: | Huang, W, Fridman, Y, Bonfil, R D, Ustach, C V, Conley-LaComb, M K, Wiesner, C, Saliganan, A, Cher, M L, Kim, H-R C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3482867/ https://www.ncbi.nlm.nih.gov/pubmed/22158043 http://dx.doi.org/10.1038/onc.2011.573 |
Ejemplares similares
-
PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling
por: Conley-LaComb, M Katie, et al.
Publicado: (2013) -
Discoidin Domain Receptors, DDR1b and DDR2, Promote Tumour Growth within Collagen but DDR1b Suppresses Experimental Lung Metastasis in HT1080 Xenografts
por: Wasinski, Benjamin, et al.
Publicado: (2020) -
Pharmacological targeting of CXCL12/CXCR4 signaling in prostate cancer bone metastasis
por: Conley-LaComb, M. Katie, et al.
Publicado: (2016) -
Are matrix metalloproteinases relevant therapeutic targets for prostate cancer bone metastasis?
por: Bonfil, R.D., et al.
Publicado: (2008) -
AUM302, a novel triple kinase PIM/PI3K/mTOR inhibitor, is a potent in vitro pancreatic cancer growth inhibitor
por: Ingle, Komala, et al.
Publicado: (2023)